Intra-Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke. - Wikidata - awgldk - TriplyDB

Intra-Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke.

Intra-Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke.

http://www.wikidata.org/entity/Q34428957

about

The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke Developing Cellular Therapies for Stroke Microcirculatory Response In Vivo on Local Intraarterial Infusion of Autogenic Adipose-derived Stem Cells or Stromal Vascular Fraction.Stem cell therapies in preclinical models of stroke associated with aging Intravenous Bone Marrow Stem Cell Grafts Preferentially Migrate to Spleen and Abrogate Chronic Inflammation in Stroke.Bone marrow mononuclear cell therapy in ischaemic stroke: a systematic review.Brain Recovery after a Plane Crash: Treatment with Growth Hormone (GH) and Neurorehabilitation: A Case Report.Tongxinluo Enhances Neurogenesis and Angiogenesis in Peri-Infarct Area and Subventricular Zone and Promotes Functional Recovery after Focal Cerebral Ischemic Infarction in Hypertensive Rats.Intra-arterial Infusion of Autologous Bone Marrow Mononuclear Stem Cells in Subacute Ischemic Stroke Patients.Safety and effectiveness of stem cell therapies in early-phase clinical trials in stroke: a systematic review and meta-analysis Stem Cell Recipes of Bone Marrow and Fish: Just What the Stroke Doctors Ordered.Stem Cell-Based Therapies for Ischemic Stroke: Preclinical Results and the Potential of Imaging-Assisted Evaluation of Donor Cell Fate and Mechanisms of Brain Regeneration.Stem cell therapies in age-related neurodegenerative diseases and stroke.Low dose Hsp90 inhibitor 17AAG protects neural progenitor cells from ischemia induced death.Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms.Developing drug strategies for the neuroprotective treatment of acute ischemic stroke.Preliminary Reports of Stereotaxic Stem Cell Transplants in Chronic Stroke Patients.Stem cell therapy: how to do it right.Recent Advances in Stem Cell-Based Therapeutics for Stroke.Metallothionein I as a direct link between therapeutic hematopoietic stem/progenitor cells and cerebral protection in stroke.Cell Therapy in Stroke-Cautious Steps Towards a Clinical Treatment.Regulated and Unregulated Clinical Trials of Stem Cell Therapies for Stroke.Mesenchymal stem cell transplantation as an effective treatment strategy for ischemic stroke in Asia: a meta-analysis of controlled trials.STROKE34 Study Protocol: A Randomized Controlled Phase IIa Trial of Intra-Arterial CD34+ Cells in Acute Ischemic Stroke.

P2860

Q26800181-C81B6DAA-DB89-4027-843A-1F098EB4D3C6 Q28087451-7D91FB3C-0CE9-4AF9-9252-DE40BD341A47 Q30819543-A307CD9C-5ABC-45A7-AB0F-83D561F77F8D Q34442610-6AC00F01-27C6-4D4A-AFBF-322DDFB0E174 Q35974305-5F9C9403-F47E-4867-9838-BAF8264E7D70 Q36112236-321FB5F1-5C8C-44F9-B486-71C1893E76C9 Q36404372-D9980468-4BFB-4F09-A1C2-99780A65B26E Q36741424-B5396700-B1C8-4061-B12F-CBE9743768AD Q37507497-0023F341-51FF-47AC-B57E-B7317A7723C7 Q38601839-E9897EA5-10E3-4CBA-8335-97827E240088 Q38773427-4C82E8B6-5D4A-4841-B340-412EBB289857 Q38903653-A633BE6C-6264-4F3B-9FA0-97CA91EE8A2A Q39017141-A02CBE50-FB0E-4A7B-B27F-11C3ECEABCC7 Q39426384-E757ACEA-AAA2-428E-A0B4-FB626DE26E9A Q39457984-CC77DB6D-77AE-4405-86AC-BF0D3825F419 Q40429078-518D7418-656D-42F4-B022-24F4312B885A Q41653901-B728C703-C584-4D60-9C4C-32D733D3BD29 Q41858276-E7A03851-F493-400E-A42F-478C24110019 Q44836823-C772DE16-F338-4C68-8868-93F61639230D Q47226785-4BDE9DAA-0DD9-4EF9-AA73-7DA53A57FC37 Q47833142-030C9F40-2135-4ED3-80FD-092A5695D02E Q48337519-D9DA4FC8-B2FE-42F3-87C1-86475EECBB52 Q55004553-42DACF5C-A6B2-4A58-B6CA-474475DCF296 Q55396569-23E7BCF8-2137-4B8D-95FA-1678208BC2E3

P2860

Intra-Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke.

http://www.wikidata.org/entity/Q34428957

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Intra-Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke.

@ast

Intra-Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke.

@en

Intra-Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke.

@nl

type

label

Intra-Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke.

@ast

Intra-Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke.

@en

Intra-Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke.

@nl

prefLabel

Intra-Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke.

@ast

Intra-Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke.

@en

Intra-Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke.

@nl

P1433

Q34428957-A902F570-5442-4A31-9C24-6B9078CA2571

P1476

Q34428957-1895FC87-65D2-45E2-80C7-733FB3367E90

P2093

Q34428957-00FE9B26-6D45-4EDD-9764-D881887096BB

Q34428957-1FDF1EE0-B012-4FF3-94F8-8FE6A927C2E7

Q34428957-6B581740-ED93-4384-8452-3D8DFDE77DF4

Q34428957-6E5E8E41-88C3-4CBE-9A9D-D3D6C9B8CA6E

Q34428957-87849F34-EAFF-4B4A-84A6-E83597A4B1BF

Q34428957-9D8A6C6E-ECD0-4C2F-81EB-AE980CA0F068

Q34428957-AF90DADC-FF79-4639-AFBC-97F5331EF1F3

Q34428957-B2BDF1B9-3102-4222-92AF-BF73C5473F5B

Q34428957-D7BEEC78-ADA0-47F0-B43E-659F39E01743

Q34428957-DBAB2796-EABA-4B3C-90FC-BD33557788A7

P2860

Q34428957-1110101E-C963-4C7D-B5CB-B6FD6D66352C

Q34428957-23A27AB2-FBEE-42D5-B80E-C0B3A41A39A2

Q34428957-2428A7DF-1FF0-4F32-BF6B-1ADFABDC3CDB

Q34428957-3115B148-3DC9-468B-9091-D0D0FF27D5B9

Q34428957-3BFE82C0-17C5-4A55-84A3-9A01C24E2032

Q34428957-61DCDA06-E39E-46F8-A76F-19F9425C5864

Q34428957-6432929A-1B92-48F8-A365-BAE1DAA783ED

Q34428957-6A01FA4B-F959-480E-ACC3-32155A495B54

Q34428957-6FEB0B10-F4EB-48FF-B0A3-0E9001F551D7

Q34428957-703A2E0A-9F7C-449A-891D-297E0A0BB923

P304

Q34428957-3E2FA614-3E81-4E86-923C-338EC5FAB4C9

P31

Q34428957-ACDE8FE3-A92C-41E5-987B-485153C11FF4

P356

Q34428957-652C7F0F-5DE4-4F54-82D1-789F3D89ED4B

P433

Q34428957-2BF93726-61C9-4CA2-BA8F-D6DFBB06D2E5

P478

Q34428957-89F98BAC-D5E0-491C-9B5C-2ABAFCDF0225

P50

Q34428957-6B1F919C-630D-4F9E-BCD4-1F3DF55B0971

P577

Q34428957-ACDEAC62-557E-471D-B840-09995A2BDE71

P5875

Q34428957-96095FA5-11E1-465F-B764-43518232D537

P698

Q34428957-E0617308-72C4-47CB-A7A7-31C4E77B61F5

P932

Q34428957-E7A3E67F-2E81-420C-9DFA-9C58134F353D

P356

P1433

Stem Cells Translational Medicine

P1476

Intra-Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke.

@en

P2093

Abdul Shlebak

http://www.w3.org/2001/XMLSchema#string

Jeremy Chataway

http://www.w3.org/2001/XMLSchema#string

Joanna Nicholls

http://www.w3.org/2001/XMLSchema#string

John Davis

http://www.w3.org/2001/XMLSchema#string

Mohammad Hamady

http://www.w3.org/2001/XMLSchema#string

Myrtle Gordon

http://www.w3.org/2001/XMLSchema#string

Nagy Habib

http://www.w3.org/2001/XMLSchema#string

Paul Bentley

http://www.w3.org/2001/XMLSchema#string

Soma Banerjee

http://www.w3.org/2001/XMLSchema#string

Steen L Jensen

http://www.w3.org/2001/XMLSchema#string

P2860

Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect

Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats

Classification and natural history of clinically identifiable subtypes of cerebral infarction

Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia.

Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats.

Implantation site and lesion topology determine efficacy of a human neural stem cell line in a rat model of chronic stroke.

Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke.

Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.

P304

1322-1330

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5966/SCTM.2013-0178

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Deborah A Williamson

P577

2014-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264632759

http://www.w3.org/2001/XMLSchema#string

P698

25107583

http://www.w3.org/2001/XMLSchema#string

P932

4214837

http://www.w3.org/2001/XMLSchema#string